Literature DB >> 2522074

Contact lens wear is associated with the appearance of plasmin in the tear fluid--preliminary results.

T Tervo1, G B van Setten, R Andersson, E M Salonen, A Vaheri, I Immonen, A Tarkkanen.   

Abstract

We determined biochemically the plasmin concentration in tear fluid from 50 externally healthy eyes and from 49 eyes during contact lens (CL) wear. After cessation of CL wear, samples were collected again from 41 of the 49 eyes. Plasmin was detected more frequently (P less than 0.0001) in the CL-wearing group (75.5%) than in the control group (20%). After the cessation of CL wear (3-21 days), the frequency of plasmin detection in tear fluid decreased significantly (P less than 0.0006) but was still higher (39%) than in the control group. We conclude that the occurrence of plasmin in tear fluid is correlated with CL wear. The proteolytic activity of plasmin may contribute to the development of corneal epithelial pathology associated with CL wear.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2522074     DOI: 10.1007/bf02169824

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  22 in total

1.  Corneal neovascularization in contact lens wearers.

Authors:  J J Arentsen
Journal:  Int Ophthalmol Clin       Date:  1986

2.  Giant papillary conjunctivitis in contact lens wearers.

Authors:  M R Allansmith; D R Korb; J V Greiner; A S Henriquez; M A Simon; V M Finnemore
Journal:  Am J Ophthalmol       Date:  1977-05       Impact factor: 5.258

3.  Corneal epithelial response to contact lens wear.

Authors:  L E Lohman
Journal:  CLAO J       Date:  1986 Jul-Sep

4.  Microbial contamination of contact lens care systems.

Authors:  P B Donzis; B J Mondino; B A Weissman; D A Bruckner
Journal:  Am J Ophthalmol       Date:  1987-10-15       Impact factor: 5.258

5.  Release of plasminogen activator by cultured corneal epithelial cells during differentiation and wound closure.

Authors:  K Y Chan
Journal:  Exp Eye Res       Date:  1986-05       Impact factor: 3.467

6.  Evidence for a role of the plasminogen activator--plasmin system in corneal ulceration.

Authors:  M Berman; R Leary; J Gage
Journal:  Invest Ophthalmol Vis Sci       Date:  1980-10       Impact factor: 4.799

7.  Corneal epithelial response of the primate eye to gas permeable corneal contact lenses: a preliminary report.

Authors:  J P Bergmanson; M Ruben; L W Chu
Journal:  Cornea       Date:  1984       Impact factor: 2.651

8.  Release of fibrinolytic activators from the cornea and conjunctiva.

Authors:  E Lantz; A Andersson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1982       Impact factor: 3.117

9.  Fibronectin in formation and degradation of the pericellular matrix.

Authors:  A Vaheri; E M Salonen; T Vartio
Journal:  Ciba Found Symp       Date:  1985

10.  Plasmin in tear fluid of patients with corneal ulcers: basis for new therapy.

Authors:  E M Salonen; T Tervo; E Törmä; A Tarkkanen; A Vaheri
Journal:  Acta Ophthalmol (Copenh)       Date:  1987-02
View more
  4 in total

1.  Pharmacokinetics of polyvalent proteinase inhibitor (aprotinin) in eye tissues.

Authors:  N B Chesnokova; T P Kuznetsova; N E Sosulina
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

2.  The appearance and possible role of plasminogen activator of urokinase type (u-PA) activity in the cornea related to soft contact lens wear in rabbits.

Authors:  J Cejková
Journal:  Doc Ophthalmol       Date:  1998       Impact factor: 2.379

3.  Histochemical changes in the rabbit cornea and plasmin activity in the tear fluid during contact lens wear. Favourable influence of protease inhibitors (aprotinin, PC5, elastatinal).

Authors:  J Cejková; Z Lojda; J Vacík; G A Digenis; S Dropcova
Journal:  Histochemistry       Date:  1992

Review 4.  Impact of Attrition, Intercellular Shear in Dry Eye Disease: When Cells are Challenged and Neurons are Triggered.

Authors:  Gysbert-Botho van Setten
Journal:  Int J Mol Sci       Date:  2020-06-18       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.